Suihai Wang

961 total citations
25 papers, 745 citations indexed

About

Suihai Wang is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Suihai Wang has authored 25 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Suihai Wang's work include Cancer Mechanisms and Therapy (5 papers), Ubiquitin and proteasome pathways (3 papers) and Circular RNAs in diseases (3 papers). Suihai Wang is often cited by papers focused on Cancer Mechanisms and Therapy (5 papers), Ubiquitin and proteasome pathways (3 papers) and Circular RNAs in diseases (3 papers). Suihai Wang collaborates with scholars based in China, United Kingdom and United States. Suihai Wang's co-authors include Yingsong Wu, Ningning Dong, Qian Xie, Ji‐Liang Li, Huan Deng, Tiancai Liu, Hongyan Du, Chunhua Lu, Xiangyi Shi and Ming O. Li and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Suihai Wang

25 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suihai Wang China 15 482 250 133 113 74 25 745
Xiaoliang Xu China 18 528 1.1× 367 1.5× 134 1.0× 113 1.0× 86 1.2× 39 862
Xuening Ji China 9 347 0.7× 209 0.8× 199 1.5× 64 0.6× 59 0.8× 16 618
Vijesh Kumar Yadav Taiwan 18 502 1.0× 310 1.2× 173 1.3× 104 0.9× 147 2.0× 41 814
Yurong Zhang China 11 413 0.9× 153 0.6× 199 1.5× 135 1.2× 91 1.2× 32 656
Xuan Luo China 15 324 0.7× 170 0.7× 87 0.7× 171 1.5× 55 0.7× 24 608
Serena De Matteis Italy 13 282 0.6× 178 0.7× 162 1.2× 119 1.1× 81 1.1× 34 658
Yu Geng China 16 386 0.8× 130 0.5× 113 0.8× 103 0.9× 56 0.8× 20 684
Peter Breslin United States 16 424 0.9× 184 0.7× 84 0.6× 176 1.6× 39 0.5× 34 737
Haijun Zhang China 15 544 1.1× 229 0.9× 211 1.6× 70 0.6× 154 2.1× 24 870
Dongxian Guan China 14 503 1.0× 250 1.0× 255 1.9× 154 1.4× 67 0.9× 17 891

Countries citing papers authored by Suihai Wang

Since Specialization
Citations

This map shows the geographic impact of Suihai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suihai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suihai Wang more than expected).

Fields of papers citing papers by Suihai Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suihai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suihai Wang. The network helps show where Suihai Wang may publish in the future.

Co-authorship network of co-authors of Suihai Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Suihai Wang. A scholar is included among the top collaborators of Suihai Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suihai Wang. Suihai Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yujing, et al.. (2024). The promotive role of lncRNA MIR205HG in proliferation, invasion, and migration of melanoma cells via the JMJD2C/ALKBH5 axis. PLoS ONE. 19(1). e0290986–e0290986. 5 indexed citations
2.
Xiao, Xing, Leli Zeng, Yueyuan Zheng, et al.. (2024). Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer. Journal of Translational Medicine. 22(1). 132–132. 5 indexed citations
3.
Dong, Ying, Bingyang Zhang, А. Н. Мурашев, et al.. (2024). Development of Cas13a-based therapy for cancer treatment. Molecular Biology Reports. 51(1). 94–94. 5 indexed citations
5.
Dong, Ningning, Xiangyi Shi, Suihai Wang, et al.. (2019). M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma. British Journal of Cancer. 121(1). 22–33. 119 indexed citations
6.
Li, Shaobin, Suihai Wang, Pietro Rubegni, et al.. (2018). Long noncoding RNA HAND2‐AS1 inhibits cancer cell proliferation, migration, and invasion in esophagus squamous cell carcinoma by regulating microRNA‐21. Journal of Cellular Biochemistry. 120(6). 9564–9571. 41 indexed citations
7.
Yao, Chen, Liping Huang, Suihai Wang, et al.. (2017). WAP four-disulfide core domain protein 2 promotes metastasis of human ovarian cancer by regulation of metastasis-associated genes. Journal of Ovarian Research. 10(1). 40–40. 7 indexed citations
8.
Li, Yue, You Li, Qianming Chen, et al.. (2017). MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis. Cancer Cell International. 17(1). 102–102. 58 indexed citations
9.
Chen, Qianming, Suihai Wang, Tiancai Liu, et al.. (2016). WAP four-disulfide core domain protein 2 gene(WFDC2) is a target of estrogen in ovarian cancer cells. Journal of Ovarian Research. 9(1). 10–10. 9 indexed citations
10.
Wang, Suihai, Wenbo Niu, Ningning Dong, et al.. (2016). Tspan5 is an independent favourable prognostic factor and suppresses tumour growth in gastric cancer. Oncotarget. 7(26). 40160–40173. 17 indexed citations
11.
Li, Yue, Chi Kwan Tsang, Suihai Wang, et al.. (2016). MAF1 suppresses AKT‐mTOR signaling and liver cancer through activation of PTEN transcription. Hepatology. 63(6). 1928–1942. 63 indexed citations
12.
Li, Yue, Ying Wang, Suihai Wang, et al.. (2014). Oridonin phosphate-induced autophagy effectively enhances cell apoptosis of human breast cancer cells. Medical Oncology. 32(1). 365–365. 48 indexed citations
13.
Du, Hongyan, Yanling Zhang, Jin‐Long Li, et al.. (2013). Effects of Angiotensin II Type 2 Receptor Overexpression on the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo. PLoS ONE. 8(12). e83754–e83754. 33 indexed citations
14.
Yao, Chen, et al.. (2013). [The effect of nicotinamide N-methytransferase overexpression on biological behaviors of SMMC7721 hepatocellar carcinoma cell line].. PubMed. 44(2). 193–5, 217. 4 indexed citations
15.
Chen, Qianming, Suihai Wang, Liang Zhao, et al.. (2012). WAP four-disulfide core domain protein 2 mediates the proliferation of human ovarian cancer cells through the regulation of growth- and apoptosis-associated genes. Oncology Reports. 29(1). 288–296. 17 indexed citations
16.
Huang, Liping, et al.. (2012). Up-Regulation of Cadherin 17 and Down-Regulation of Homeodomain Protein CDX2 Correlate With Tumor Progression and Unfavorable Prognosis in Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 22(7). 1170–1176. 14 indexed citations
17.
Wang, Suihai, Xiang Huang, Yue Li, et al.. (2011). RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway. Hepatology. 53(6). 1932–1942. 33 indexed citations
18.
Liu, Tiancai, et al.. (2010). Targeting Procalcitonin with Novel Murine Monoclonal Antibodies. Hybridoma. 29(3). 189–194. 4 indexed citations
19.
Yao, Chen, et al.. (2009). Effect of HE4 overexpression on the proliferation and invasion abilities of the ovarian cancer cell line HO8910.. Journal of Tropical Medicine. 9(6). 605–633. 1 indexed citations
20.
Du, Hongyan, Xiang Huang, Suihai Wang, et al.. (2009). PSMA7, A Potential Biomarker of Diseases. Protein and Peptide Letters. 16(5). 486–489. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026